Non-alcoholic fatty liver disease (NAFLD) in children

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 1, 2005, Pages 2306-2318

  Roberts, Eve A ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Fatty liver; Hyperinsulinemia; Insulin resistance; Non alcoholic; Obesity; Review; Steatosis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ALPHA TOCOPHEROL; BETAINE; INSULIN RECEPTOR; METFORMIN; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLISM; ALSTROM SYNDROME; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOSOMAL RECESSIVE DISORDER; BARDET BIEDL SYNDROME; CHILD; CHILDHOOD; CHRONIC LIVER DISEASE; CLINICAL TRIAL; COHEN SYNDROME; DIAGNOSTIC PROCEDURE; DIET; DISEASE ASSOCIATION; DRUG THERAPY; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPIDEMIC; ETHNIC GROUP; EXERCISE; EYE MALFORMATION; FAT INTAKE; FATTY LIVER; FEMALE; GENETIC RISK; GLYCEMIC INDEX; HEALTH; HEREDITY; HISTOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; IMAGING; INSULIN RESISTANCE; KABUKI MAKEUP SYNDROME; LABORATORY; LIPID BLOOD LEVEL; LIPODYSTROPHY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PRADER WILLI SYNDROME; SPECTRUM; STEATOSIS; TURNER SYNDROME; WEIGHT REDUCTION;

EID: 21344475102     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1699     Document Type: Article

References (142)

1. Ariza, A. J., R. S. Greenberg & R. Unger: Childhood overweight: management approaches in young children. Pediatr Ann 33, 33-38 (2004)
2. Flodmark, C. E., I. Lissau, L. A. Moreno, A. Pietrobelli & K. Widhalm. New insights into the field of children and adolescents' obesity: the European perspective. Int J Obes Relat Metab Disord 28, 1189-1196 (2004)
3. Strauss, R. S. & H. A. Pollack: Epidemic increase in childhood overweight, 1986-1998. JAMA 286, 2845-2848 (2001)
4. Yoshinaga, M., A. Shimago, C. Koriyama, Y. Nomura, K. Miyata, J. Hashiguchi & K. Arima: Rapid increase in the prevalence of obesity in elementary school children. Int J Obes Relat Metab Disord 28, 494-499 (2004)
5. Lobstein, T., L. Baur & R. Uauy: Obesity in children and young people: a crisis in public health. Obes Rev 5 Suppl 1, 4-104 (2004)
6. Power, C., J. K. Lake & T. Cole: Measurement and long-term health risks of child and adolescent fatness. Int J Obes Relat Metab Disord 21, 507-526 (1997)
7. Kiess, W., A. Reich, G. Muller, K. Meyer, A. Galler, J. Bennek & J. Kratzsch: Clinical aspects of obesity in childhood and adolescence-diagnosis, treatment and prevention. Int J Obes Relat Metab Disord 25 Suppl 1, S75-S79 (2001)
8. Cole, T. J., M. C. Bellizzi, K. M. Flegal & W. H. Dietz: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320, 1240-1243 (2000)
9. McCarthy, H. D., S. M. Ellis & T. J. Cole: Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference. BMJ 326, 624 (2003)
10. Taylor, R. W., I. E. Jones, S. M. Williams & A. Goulding: Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3-19 y. Am J Clin Nutr 72, 490-495 (2000)
11. Tremblay, M. S. & J. D. Willms: Secular trends in the body mass index of Canadian children. Can Med Assoc J 163, 1429-1433 (2000)
12. Livingstone, B.: Epidemiology of childhood obesity in Europe. Eur J Pediatr 159 Suppl 1, S14-34 (2000)
13. Livingstone, M. B.: Childhood obesity in Europe: a growing concern. Public Health Nutr 4, 109-116 (2001)
14. James, P. T., N. Rigby & R. Leach: The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11, 3-8 (2004)
15. Canning, P. M., M. L. Courage & L. M. Frizzell: Prevalence of overweight and obesity in a provincial population of Canadian preschool children. Can Med Assoc J 171, 240-242 (2004)
16. Bundred, P., D. Kitchiner & I. Buchan: Prevalence of overweight and obese children between 1989 and 1998: population based series of cross sectional studies. BMJ 322, 326-328 (2001)
17. Nelson, J. A., M. A. Chiasson & V. Ford: Childhood overweight in a New York City WIC population. Am J Public Health 94, 458-462 (2004)
18. Ludwig, D. S., K. E. Peterson & S. L. Gortmaker: Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357, 505-508 (2001)
19. Mrdjenovic & D. Levitysky: Nutritional and energetic consequences of sweetened drinks consuption in 6- to 13-year-old children. J Pediatr 142, 604-610 (2003)
20. James, J., P. Thomas, D. Cavan & D. Kerr: Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ 328, 1237 (2004)
21. Robinson, T. N.: Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA 282, 1561-1567 (1999)
22. Kaur, H., W. S. Choi, M. S. Mayo & K. J. Harris: Duration of television watching is associated with increased body mass index. J Pediatr 143, 506-511 (2003)
23. Matheson, D. M., J. D. Killen, Y. Wang, A. Varady & T. N. Robinson: Children's food consumption during television viewing. Am J Clin Nutr 79, 1088-1094 (2004)
24. Vandewater, E. A., M. S. Shim & A. G. Caplovitz: Linking obesity and activity level with children's television and video game. J Adolesc 27, 71-85 (2004)
25. Zametkin, A. J., C. K. Zoon, H. W. Klein & S. Munson: Psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 43, 134-150 (2004)
26. Datar, A., R. Sturm & J. L. Magnabosco: Childhood overweight and academic performance: national study of kindergartners and first-graders. Obes Res 12, 58-68 (2004)
27. Janssen, I., W. M. Craig, W. F. Boyce & W. Pickett: Associations between overweight and obesity with bullying behaviors in school-aged children. Pediatrics 113, 1187-1194 (2004)
28. Fagot-Campagna, A., D. J. Pettitt, M. M. Engelgau, N. R. Burrows, L. S. Geiss, R. Valdez, G. L. Deckles, J. Saaddine, E. W. Gregg, D. F. Williamson & K. M. Narayan: Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136, 664-772 (2000)
29. Sorof, J. & S. Daniels: Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40, 441-447 (2002)
30. Saadeh, S., Z. M. Younossi, E. M. Remer, T. Gramlich, J. P. Ong, M. Hurley, K. D. Mullen, J. N. Cooper & M. J. Sheridan: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745-750 (2002)
31. Mathiesen, U. L., L. E. Franzen, H. Aselius, M. Resjo, L. Jacobsson, U. Foberg, A. Fryden & G. Bodemar: Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34, 516-522 (2002)
32. Tominaga, K., J. H. Kurata, Y. K. Chen, E. Fujimoto, S. Miyagawa, I. Abe & Y. Kusano: Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 40, 2002-2009 (1995)
33. Bergomi, A., L. Iughetti, N. Corciulo, P. Peverelli, V. Cammareri, G. Grifi, F. Celi, G. MOrino, D. Agnello & F. DeLuca: Italian multicenter study on liver damage in pediatric obesity. Int J Obes Relat Metab Disord 22(suppl 4), S22 (abstr) (1998)
34. Tazawa, Y., H. Noguchi, F. Nishiomiya & G. Takada: Serum alanine aminotranferase activity in obese children. Acta Paediatr 86, 238-241 (1997)
35. Guzzaloni, G., G. Grugni, A. Minocci, D. Moro & F. Morabito: Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 24, 772-776 (2000)
36. Chan, D. F., A. M. Li, W. C. Chu, M. H. Chan, E. M. Wong, E. K. Liu, I. H. Chan, J. Yin, C. W. Lam, T. F. Fok & E. A. Nelson: Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28, 1257-1263 (2004)
37. Fishbein, M. H., M. Miner, C. Mogren & J. Chalekson: The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr 36, 54-61 (2003)
38. Strauss, R. S., S. E. Barlow & W. H. Dietz: Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 136, 727-733 (2000)
39. Engelmann, G., H. Lenhartz & J. Grulich-Henn: Obesity and metabolic syndrome in children and adolescents (letter). N Engl J Med 351, 1146 (2004)
40. Brunt, E. M.: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21, 3-16 (2001)
41. Brunt, E. M.: Nonalcoholic steatohepatitis. Semin Liver Dis 24, 3-20 (2004)
42. Struben, V. M., E. E. Hespenheide & S. H. Caldwell: Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108, 9-13 (2000)
43. Caldwell, S. H. & D. M. Crespo: The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40, 578-584 (2004)
44. Abrams, G. A., S. S. Kunde, A. J. Lazenby & R. H. Clements: Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology 40, 475-483 (2004)
45. Sanyal, A. J., C. Campbell-Sargent, F. Mirshahi, W. B. Rizzo, M. J. Contos, R. K. Sterling, V. A. Luketic, M. L. Shiftman & J. N. Clore: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183-1192 (2001)
46. Caldwell, S. H., C. Y. Chang, R. K. Nakamoto & L. Krugner-Higby: Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 8, 595-617 (2004)
47. Sobaniec-Lotowska, M. E. & D. M. Lebensztejn: Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol 98, 1664-1665 (2003)
48. Moran, J. R., F. K. Ghishan, S. A. Halter & H. L. Greene: Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78, 374-377 (1983)
49. Kinugasa, A., K. Tsunamoto, N. Furukawa, T. Sawada, T. Kusunoki & N. Shimada: Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gatroenterol Nutrit 3, 408-414 (1984)
50. Vajro, P., A. Fontanella, C. Perna, G. Orso, M. Tedesco & A. De Vincenzo: Persistent hypertransaminasemia resolving after weight reduction in obese children. J Pediatr 125, 239-241 (1994)
51. Baldridge, A. D., A. R. Perez-Atayde, F. Graeme-Cooke, L. Higgins & J. E. Lavine: Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127, 700-704 (1995)
52. Manton, N. D., J. Lipsett, D. J. Moore, G. P. Davidson, A. J. Bourne & R. T. Couper: Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 173, 476-479 (2000)
53. Kocak, N., A. Yuce, F. Gurakan & H. Ozen: Obesity: a cause of steatohepatitis in children. Am J Gastroenterol 95, 1099-1100 (2000)
54. Sathya, P., S. Martin & F. Alvarez: Nonalcoholic fatty liver disease (NAFLD) in children. Curr Opin Pediatr 14, 593-600 (2002)
55. Willner, I. R., B. Waters, S. R. Patil, A. Reuben, J. Morelli & C. A. Riely: Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96, 2957-2961 (2001)
56. Rashid, M. & E. A. Roberts: Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30, 48-53 (2000)
57. Molleston, J. P., F. White, J. Teckman & J. F. Fitzgerald: Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 97, 2460-2462 (2002)
58. Adams, L. A., A. Feldstein, K. D. Lindor & P. Angulo: Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 39, 909-914 (2004)
59. Basenau, D., U. Stehphani & G. Fischer: [Development of complete liver cirrhosis in hyperphagia-induced fatty liver]. Klin Pädiatr 206, 62-64 (1994)
60. Altuntas, B., B. Ozcakar, A. Bideci & P. Cinaz: Cirrhotic outcome in patients with craniopharyngioma. J Pediatr Endocrinol Metab 15, 1057-1058 (2002)
61. Squires, R. H., Jr. & M. J. Lopez: Steatohepatitis (SH) is a serious condition in Hispanic children (abstr.). Hepatology 32, 418A (2000)
62. Kerkar, N., M. Aw, C. Buchanan, N. Hadzic, A. Dhawan, D. Vergani & G. Mieli-Vergani: Non-alcoholic fatty liver disease in children (abstr.). Hepatology 36, 730A (2002)
63. Evans, H. M., U. Baumann, P. J. McKiernan, J. M. W. Kirk, G. Shaikh & D. A. Kelly: Fatty liver disease in children in the West Midlands, United Kingdom (abstr.). J Pediatr Gastroenterol Nutr 39(Suppl. 1), S52 (2004)
64. Stefan, M. & R. D. Nicholls: What have rare genetic syndromes taught us about the pathophysiology of the common forms of obesity? Curr Diab Rep 4, 143-150 (2004)
65. Green, J. S., P. S. Parfrey, J. D. Harnett, N. R. Farid, B. C. Cramer, G. Johnson, O. Heath, P. J. McManamon, E. O'Leary & W. Pryse-Phillips: The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 321, 1002-1009 (1989)
66. Iannello, S., P. Bosco, A. Cavaleri, M. Camuto, P. Milazzo & F. Belfiore: A review of the literature of Bardet-Biedl disease and report of three cases associated with metabolic syndrome and diagnosed after the age of fifty. Obes Rev 3, 123-135 (2002)
67. Katsanis, N., J. R. Lupski & P. L. Beales: Exploring the molecular basis of Bardet-Biedl syndrome. Hum Mol Genet 10, 2293-2299 (2001)
68. Mykytyn, K., D. Y. Nishimura, C. C. Searby, M. Shastri, H. J. Yen, J. S. Beck, T. Braun, L. M. Streb, A. S. Cornier, G. F. Cox, A. B. Fulton, R. Carmi, G. Luleci, S. C. Chandrasekharappa, F. S. Collins, S. G. Jacobson, J. R. Heckenlively, R. G. Weleber, E. M. Stone & V. C. Sheffield: Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet 31, 435-438 (2002)
69. Pagon, R. A., J. E. Haas, A. H. Bunt & K. A. Rodaway: Hepatic involvement in the Bardet-Biedl syndrome. Am J Med Genet 13, 373-381 (1982)
70. Michaud, J. L., E. Heon, F. Guilbert, J. Weill, B. Puech, L. Benson, J. F. Smallhom, C.T. Shuman, J. R. Buncic, A. V. Levin, R. Weksberg & G. M. Breviere: Natural history of Alstrom syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr 128, 225-229 (1996)
71. Russell-Eggitt, I. M., P. T. Clayton, R. Coffey, A. Kriss, D. S. Taylor & J. F. Taylor Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology 105, 1274-1280 (1998)
72. Hearn, T., G. L. Renforth, C. Spalluto, N. A. Hanley, K. Piper, S. Brickwood, C. White, V. Connolly, J. F. Taylor, I. Russell-Eggitt, D. Bonneau, M. Walker & D. I. Wilson: Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet 31, 79-83 (2002)
73. Collin, G. B., J. D. Marshall, A. Ikeda, W. V. So, I. Russell-Eggitt, P. Maffei, S. Beck, C. F. Boerkoel, N. Sicolo, M. Martin, P. M. Nishina & J. K. Naggert: Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 31, 74-78 (2002)
74. Connolly, M. B., J. E. Jan, R. M. Couch, L. T. Wong, J. E. Dimmick & J. M. Rigg: Hepatic dysfunction in Alstrom disease. Am J Med Genet 40, 421-424 (1991)
75. Awazu, M., T. Tanaka, S. Sato, M. Anzo, M. Higuchi, K. Yamazaki & N. Matsuo: Hepatic dysfunction in two sibs with Alstrom syndrome: case report and review of the literature. Am J Med Genet 69, 13-16 (1997)
76. Quiros-Tejeira, R. E., J. Vargas & M. E. Ament: Early-onset liver disease complicated with acute liver failure in Alstrom syndrome. Am J Med Genet 101, 9-11 (2001)
77. Satman, I., M. T. Yilmaz, N. Gursoy, K. Karsidag, N. Dinccag, T. Ovali, S. Karadeniz, V. Uysal, Z. Bugra, A. Okten & S. Devrim: Evaluation of insulin resistant diabetes mellitus in Alstrom syndrome: a long-term prospective follow-up of three siblings. Diabetes Res Clin Pract 56, 189-196 (2002)
78. Paisey, R. B., C. M. Carey, L. Bower, J. Marshall, P. Taylor, P. Maffei & P. Mansell: Hypertriglyceridaemia in Alstrom's syndrome: causes and associations in 37 cases. Clin Endocrinol (Oxf) 60, 228-231 (2004)
79. Keskin, M., M. E. Atabek & S. Kurtoglu: Bardet-Biedl syndrome with syndrome X: a patient report. J Pediatr Endocrinol Metab 17, 913-915 (2004)
80. Iannello, S., P. Bosco, M. Camuto, A. Cavaleri, P. Milazzo & F. Belfiore: A mild form of Alstrom disease associated with metabolic syndrome and very high fasting serum free fatty acids: two cases diagnosed in adult age. Am J Med Sci 327, 284-288 (2004)
81. Boor, R., J. Herwig, J. Schrezenmeir, B. F. Pontz & W. Schonberger: Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation. Am J Med Genet 45, 649-653 (1993)
82. Lewy, V. D., K. Danadian, S. F. Witchel & S. Arslanian: Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 138, 38-44 (2001)
83. Conway, G. S. & H. S. Jacobs: Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity. Postgrad Med J 66, 536-538 (1990)
84. Dunaif, A.: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endoc Rev 18, 774-800 (1997)
85. Parsanezhad, M. E., S. Alborzi, A. Zarei, S. Dehbashi & G. Omrani: Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin. Int J Gynaecol Obstet 75, 43-50 (2001)
86. Nardo, L. G. & R. Rai: Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects. Gynecol Endocrinol 15, 373-380 (2001)
87. De Conciliis, B., G. Passannanti, L. Romano & R. Santarpia: Effects of metformin on the insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome. Minerva Ginecol 53, 239-250 (2001)
88. Batukan, C. & B. Baysal: Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 265, 124-127 (2001)
89. Reitman, M. L., E. Arioglu, O. Gavrilova & S. I. Taylor: Lipoatrophy revisited. Trends Endocrinol Metab 11, 410-416 (2000)
90. Powell, E. E., J. Searle & R. Mortimer: Steatohepatitis associated with limb lipodystrophy. Gastroenterology 97, 1022-1024 (1989)
91. Cauble, M. S., R. Gilroy, M. F. Sorrell, M. E. Mailliard, D. L. Sudan, J. C. Anderson, J. L. Wisecarver, S. Balakrishnan & J. L. Larsen: Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. Transplantation 71, 892-895 (2001)
92. Agarwal, A. K., E. Arioglu, S. de Almeida, N. Akkoc, S. I. Taylor, A. M. Bowcock, R. I. Barnes & A. Garg: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chronosome 9q34 Nat Genet 31, 21-23 (2002)
93. Magre, J., M. Delepine, E. Khallouf, T. Gedde-Dahl, Jr., L. Van Maldergem, E. Sobel, J. Papp, M. Meier, A. Megarbane, A. Bachy, A. Verloes, F. H. d'Abronzo, E. Seemanova, R. Assan, N. Baudic, C. Bourut, P. Czernichow, F. Huet, F. Grigorescu, M. de Kerdanet, D. Lacombe, P. Labrune, M. Lanza, H. Loret, F. Matsuda, J. Navarro, A. Nivelon-Chevalier, M. Polak, J. J. Robert, P. Tric, N. Tubiana-Rufi, C. Vigouroux, J. Weissenbach, S. Savasta, J. A. Maassen, O. Trygstad, P. Bogalho, P. Freitas, J. L. Medina, F. Bonnicci, B. I. Joffe, G. Loyson, V. R. Panz, F. J. Raal, S. O'Rahilly, T. Stephenson, C. R. Kahn, M. Lathrop & J. Capeau: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28, 365-370 (2001)
94. Shackleton, S., D. J. Lloyd, S. N. Jackson, R. Evans, M. F. Niermeijer, B. M. Singh, H. Schmidt, G. Brabant, S. Kumar, P. N. Durrington, S. Gregory, S. O'Rahilly & R. C. Trembath: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24, 153-156 (2000)
95. Lloyd, D. J., R. C. Trembath & S. Shackleton: A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Molec Genet 11, 769-777 (2002)
96. Agarwal, A. K. & A. Garg: A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87, 408-411 (2002)
97. Salerno, M., S. DiMaio, N. Gasparini, M. Rizzo, P. Ferri & P. Vajro: Liver abnormalities in Turner syndrome. Eur J Pediatr 158, 618-623 (1999)
98. Sato, H., S. Miyamoto & N. Sasaki: Liver abnormality in Turner syndrome. Eur J Pediatr 160, 59 (2001)
99. Kivitie-Kallio, S. & R. Norio: Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet 102, 125-135 (2001)
100. Kumandas, S., H. Gumus, S. Kurtoglu, B. Elmas & O. Kontas: Cohen syndrome with acanthosis nigricans and insulin resistance. J Pediatr Endoscrinol Metab 14, 807-810 (2001)
101. Goldstone, A. P.: Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 15, 12-20 (2004)
102. Matsumoto, N. & N. Niikawa: Kabuki make-up syndrome: a review. Am J Med Genet 117C, 57-65 (2003)
103. White, S. M., E. M. Thompson, A. Kidd, R. Savarirayan, A. Turner, D. Amor, M. B. Delatycki, M. Fahey, A. Baxendale, S. White, E. Haan, K. Gibson, J. L. Halliday & A. Bankier: Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet 127A, 118-27 (2004)
104. Marchesini, G., M. Brizi, A. M. Morselli-Labate, G. Bianchi, E. Bugianesi, A. J. McCullough, G. Forlani & N. Melchionda: Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107, 450-455 (1999)
105. Pagano, G., G. Pacini, G. Musso, R. Gambino, F. Mecca, N. Depetris, M. Cassader, E. David, P. Cavallo-Perin & M. Rizzetto: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35, 367-372 (2002)
106. Chitturi, S., S. Abeygunasekera, G. C. Farrell, J. Holmes-Walker, J. M. Hui, C. Fung, R. Karim, R. Lin, D. Samarasinghe, C. Liddle, M. Weltman & J. George: NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379 (2002)
107. Cortez-Pinto, H., M. E. Camilo, A. Baptista, A. G. De Oliveira & M. C. De Moura: Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 18, 353-358 (1999)
108. Luyckx, F. H., P. J. Lefebvre & A. J. Scheen: Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 26, 98-106 (2000)
109. Wanless, I. R. & J. S. Lentz: Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12, 1106-1110 (1990)
110. de Almeida, I. T., H. Cortez-Pinto, G. Figaldo, D. Rodreigues & M. E. Camilo: Plasma total and free fatty acids compsition in human non-alcoholic steatohepatitis. Clin Nutr 21, 219-223 (2002)
111. Cruz, P. D., Jr. & J. A. Hud, Jr.: Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 98, 82S-85S (1992)
112. Brockow, K., V. Steinkraus, F. Rinninger, D. Abeck & J. Ring: Acanthosis nigricans: a marker for hyperinsulinemia. Pediatr Dermatol 12, 323-326 (1995)
113. Stuart, C. A., C. R. Gilkison, M. M. Smith, A. M. Bosma, B. S. Keenan & M. Nagamani: Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila) 37, 73-79 (1998)
114. Hermanns-Le, T., J. F. Hermanns & G. E. Pierard: Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol 19, 12-14 (2002)
115. Torley, D. & C. S. Munro: Genes, growth factors and acanthosis nigricans. Br J Dermatol 147, 1096-1101 (2002)
116. Kerem, N., H. Guttmann & Z. Hochberg: The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2. Horm Res 55, 298-304 (2001)
117. Kahn, C. R., J. S. Flier, R. S. Bar, J. A. Archer, P. Gorden, M. M. Martin & J. Roth: The syndrome of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med 294, 739-745 (1976)
118. Yanovski, J. A. & E. Arioglu: When a child can't clean her neck. J Pediatr 138, 608 (2001)
119. Zuhri-Yafi, M. I., P. G. Brosnan & D. S. Hardin: Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 15 Suppl 1, 541-546 (2002)
120. Schwimmer, J. B., R. Deutsch, J. B. Rauch, C. Behling, R. Newbury & J. E. Lavine: Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143, 500-505 (2003)
121. Weiss, R., J. Dziura, T. S. Burgert, W. V. Tamborlane, S. E. Taksali, C. W. Yeckel, K. Allen, M. Lopes, M. Savoye, J. Morrison, R. S. Sherwin & S. Caprio: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350, 2362-2374 (2004)
122. Gil-Campos, M., R. R. Canete & A. Gil: Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23, 963-974 (2004)
123. Maeda, N., I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi & Y. Matsuzawa: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8, 731-737 (2002)
124. Asayama, K., H. Hayashibe, K. Dobashi, N. Uchida, T. Nakane, K. Kodera, A. Shirahata & M. Taniyama: Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 11, 1072-1079 (2003)
125. Diamond, F. B., Jr., D. Cuthbertson, S. Hanna & D. Eichler: Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 17, 1069-1075 (2004)
126. Bacha, F., R. Saad, N. Gungor & S. A. Arslanian: Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27, 547-552 (2004)
127. Wang, J., S. Obici, K. Morgan, N. Barzilai, Z. Feng & L. Rossetti: Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50, 2786-2791 (2001)
128. Uygun, A., A. Kadayifci, Z. Yesilova, A. Erdil, H. Yaman, M. Saka, M.S. Deveci, S. Bagci, M. Gulsen, N. Karaeren & K. Dagalp: Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95, 3584-3589 (2000)
129. Kennedy, A., T. W. Gettys, P. Watson, P. Wallace, E. Ganaway, Q. Pan & W. T. Garvey: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82, 1293-1300 (1997)
130. Oral, E.A., V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, P. Snell, A. J. Wagner, A. M. DePaoli, M. L. Reitman, S. I. Taylor, P. Gorden & A. Garg: Leptin-replacement therapy for lipodystrophy. N Engl J Med 346, 570-578 (2002)
131. Roberts, E.A.: Steatohepatitis in children. Best Pract Res Clin Gastroenterol 16, 749-765 (2002)
132. Vajro, P., A. Franzese, G. Valerio, M. P. Iannucci & N. Aragione: Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 136, 739-743 (2000)
133. Spieth, L. E., J. D. Harnish, C. M. Lenders, L. B. Raezer, M. A. Pereira, S. J. Hangen & D. S. Ludwig: A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 154, 947-951 (2000)
134. Ludwig, D. S.: The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287, 2414-2423 (2002)
135. Goldfield, G. S., L. H. Epstein, C. K. Kilanowski, R. A. Paluch & B. Kogut-Bossler: Cost-effectiveness of group and mixed family-based treatment for childhood obesity. Int J Obes Relat Metab Disord 25, 1843-1849 (2001)
136. Riccardi, G., R. Giacco & A. A. Rivellese: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23, 447-456 (2004)
137. Lavine, J. E.: Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 136, 734-738 (2000)
138. Marchesini, G., M. Brizi, G. Bianchi, S. Tomassetti, M. Zoli & N. Melchionda: Metformin in non-alcoholic steatohepatitis. Lancet 358, 893-894 (2001)
139. Kay, J. P., R. Alemzadeh, G. Langley, L. D'Angelo, P. Smith & S. Holshouser: Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50, 1457-1461 (2001)
140. Jones, K. L., S. Arslanian, V. A. Peterokova, J. S. Park & M. J. Tomlinson: Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25, 89-94 (2002)
141. Arslanian, S. A., V. Lewy, K. Danadian & R. Saad: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 87, 1555-1559 (2002)
142. Chan, N. N., M. D. Feher & N. A. Bridges: Metformin therapy for diabetes in Prader-Willi syndrome. J R Soc Med 91, 598 (1998)